JPRN-jRCTs052190087招募中未知
Repetitive transcranial magnetic stimulation of the precentral-gyrus in the relief of fibromyalgia pain: an international multicenter controlled adaptive trial - TMSFFI
Kishima Haruhiko0 个研究点目标入组 10 人开始时间: 2019年12月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old(—)
- 性别
- Female
入选标准
- •(1) Female patients with diagnosis fibromyalgia according to the ACR 2016 criteria (patient satisfies modified 2016 fibromyalgia criteria if the following 3 conditions are met
- •i) widespread pain index (WPI) >= 7 and symptom severity scale (SSS) score >= 5 or WPI of 3-6 and SSS score >= 9.
- •ii) Generalized pain, defined as pain in at least 4 of 5 regions, must be present. Jaw, chest, and abdominal pain are not included in generalized pain definition.
- •iii) Symptoms have been generally present for at least 3 months.
- •(2) Persistent pain for more than 6 months before enrollment.
- •(3) Stable treatment for atleast 2 months before enrollment and throughout the study.
- •(4) Age of 20 to 80 years.
- •(5) Right-handed patients.
- •(6) Be able to understand study protocol and give signed, written informed consent.
- •(7) NRS score >= 4/10
排除标准
- •(1) Known abuse of alcohol or illicit drugs
- •(2) Known psychiatric conditions (DSM-V)
- •(3) Contraindications to rTMS (Head trauma or concussion, metal implants in the skull, cardiac pacemaker, medication infusion devices, previous troubles with TMS or MRI)
- •(4) Pregnancy or breastfeeding
- •Being under chronic contraceptive use (intrauterine dispositive or oral contraceptive)
- •(5) Other medical conditions demand hospitalization;
- •(6) Participation in other clinical studies at the same time
- •(7) Use of strong opioids
- •(8) Transcranial magnetic stimulation-naive
- •(9) Inflammatory rheumatic disease, autoimmune disease, or other painful disorders that might confound the assessment of fibromyalgia pain
- •(10) On medications known to increase the risk of TMS-induced seizures (eg, theophylline, Ritalin, high-dose thyroid supplementation)
- •(11) If they had medication changes within 4 weeks of starting the trial or during the trial
- •(12) Neurologic disorders
- •(13) If they had stroke, bipolar disorder, or schizophrenia
研究者
相似试验
终止
不适用
The effectiveness of repetitive transcranial magnetic stimulation in the treatment of fibromyalgiaFibromyalgiaACTRN12613000561785Dr Bernadette Fitzgibbon40
尚未招募
Unknown
Transcranial Magnetic stimulation in Writers cramp patientsCTRI/2024/04/065811Indian Council of Medical Research
已完成
不适用
Repetitive transcranial magnetic stimulation in preventing the transition from acute to sustained pain: A randomised controlled trialMechanical hyperalgesiaPainFunctional disabilityMuscle sorenessACTRN12618001366246Western Sydney University30
尚未招募
Unknown
se of Repetitive Transcranial Magnetic Stimulation in the treatment of DementiaRBR-3m5rqzhInstituto de Psiquiatria da Universidade Federal do Rio de Janeiro
尚未招募
不适用
A study evaluating the effect of rTMS in patients with treatment resistant obsessive compulsive disorderCTRI/2018/02/012246All India Institute of Medical Sciences New Delhi
